Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : N::A symbols : VNDA save search
Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak
Published: 2024-04-17 (Crawled : 13:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 35.5%
H: 4.61%
C: -3.32%
unsolicited pharmaceuticals
Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia
Published: 2024-03-06 (Crawled : 12:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: -4.4%
hetlioz fda update treatment pharmaceuticals
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-07 (Crawled : 21:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -2.28%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.27%
H: 20.82%
C: 11.51%
year pharmaceuticals financial results
Court Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag Hearing Request by March 5, 2024
Published: 2024-01-30 (Crawled : 00:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.0%
H: 0.26%
C: -3.95%
fda resolve
Vanda Pharmaceuticals Announces a U.S. Patent Allowance for PONVORY® (ponesimod) in the U.S.
Published: 2024-01-26 (Crawled : 04:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.79%
H: 1.05%
C: -1.83%
ponvory patent pharmaceuticals
Federal Court Allows Vanda Pharmaceuticals' Lawsuit to Proceed Against the U.S. Food and Drug Administration
Published: 2024-01-19 (Crawled : 21:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
| Email alert
Add to watchlist
drug food
Vanda Pharmaceuticals announces the publication of Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study in the Journal of Clinical Psychiatry
Published: 2024-01-17 (Crawled : 21:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.27%
H: 1.19%
C: -2.12%
publication pharmaceuticals study
Vanda Pharmaceuticals Acquires U.S. and Canadian Rights to PONVORY® (ponesimod), a Selective S1P1R Modulator Approved for Patients with Relapsing Multiple Sclerosis
Published: 2023-12-07 (Crawled : 12:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 6.68%
H: 1.39%
C: -7.89%
ponvory approved sclerosis pharmaceuticals
Vanda Pharmaceuticals Announces that U.S. Food and Drug Administration Accepts New Drug Application for Tradipitant for the Treatment of Gastroparesis
Published: 2023-12-04 (Crawled : 23:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 2.08%
H: 1.53%
C: 0.76%
drug food treatment pharmaceuticals application
Insomnia Therapeutics Market to grow by USD 1 billion from 2022-2027 | North America to account for 60% of market growth - Technavio
Published: 2023-11-27 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.89%
H: 0.02%
C: 0.02%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -4.49%
H: 6.23%
C: 3.42%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.21%
H: 0.21%
C: -1.93%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.07%
H: 0.28%
C: 0.21%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.24%
H: 0.03%
C: -0.39%
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 2.81%
H: 0.0%
C: -3.01%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.41%
H: 0.87%
C: 0.0%
america therapeutics growth market
Vanda Pharmaceuticals to Announce Third Quarter 2023 Financial Results on November 8, 2023
Published: 2023-11-01 (Crawled : 21:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: -0.23%
H: 2.98%
C: 2.52%
pharmaceuticals financial results
Vanda Pharmaceuticals Intends to Petition the U.S. Supreme Court in its HETLIOZ® ANDA Litigation
Published: 2023-10-20 (Crawled : 11:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: -0.23%
H: 2.79%
C: 0.93%
hetlioz pharmaceuticals
Vanda Pharmaceuticals Announces Participation in the Jefferies Inaugural Biotech CNS/Neuro Summit
Published: 2023-10-05 (Crawled : 23:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 2.02%
H: 2.86%
C: 0.66%
biotech pharmaceuticals
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
Published: 2023-09-06 (Crawled : 22:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: -0.91%
H: 5.75%
C: 5.06%
conference pharmaceuticals global
Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
Published: 2023-09-01 (Crawled : 23:00) - prnewswire.com
HE | $10.91 6.86% -0.18% 3.2M
|
Utilities
| Email alert
Add to watchlist
SPGI | $412.56 -0.2% 0.0% 1.1M
|
Commercial Services
| Email alert
Add to watchlist
MTN | News | $202.94 -5.0% 0.0% 1.7M
|
Consumer Services
| Email alert
Add to watchlist
BX | $118.4 -1.6% 0.0% 4M
|
Finance
| Email alert
Add to watchlist
APLE | $15.14 1.41% 0.2% 1.8M
|
Finance
| Email alert
Add to watchlist
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
| Email alert
Add to watchlist
NWL | $6.89 -0.29% -0.29% 3.3M
|
Producer Manufacturing
| Email alert
Add to watchlist
ENR | $28.41 1.57% 0.63% 550K
|
Consumer Non-Durables
| Email alert
Add to watchlist
EGHT S | $2.185 1.63% 1.6% 960K
|
Technology Services
| Email alert
Add to watchlist
HASI | $24.95 2.51% 0.0% 840K
|
Finance
| Email alert
Add to watchlist
TSE | $2.76 0.73% 0.0% 280K
|
Process Industries
| Email alert
Add to watchlist
LNC | $27.65 1.54% 1.77% 1.8M
|
Finance
| Email alert
Add to watchlist
ST | $33.7 0.57% 0.0% 1.7M
|
Electronic Technology
| Email alert
Add to watchlist
FNF | $48.77 2.5% 0.0% 1.1M
|
Finance
| Email alert
Add to watchlist
BXMT A | $18.54 1.15% 0.0% 1.5M
|
Finance
| Email alert
Add to watchlist
LBRT | $22.38 1.27% -0.98% 3.8M
|
Industrial Services
| Email alert
Add to watchlist
FF | $5.63 0.9% 0.0% 520K
|
Process Industries
| Email alert
Add to watchlist
SXT | $69.14 1.33% 0.0% 190K
|
Distribution Services
| Email alert
Add to watchlist
RMAX | $7.25 1.54% 0.0% 220K
|
Finance
| Email alert
Add to watchlist
VST | $65.66 -0.33% 0.0% 7.5M
|
Utilities
| Email alert
Add to watchlist
FL | $21.71 0.46% -0.18% 2.1M
|
Retail Trade
| Email alert
Add to watchlist
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
| Email alert
Add to watchlist
RBC A | $244.86 0.85% 0.0% 240K
|
Producer Manufacturing
| Email alert
Add to watchlist
ANIK | $25.84 1.61% 1.59% 49K
|
Health Technology
| Email alert
Add to watchlist
CATY A | $36.0 3.87% 3.72% 320K
|
Finance
| Email alert
Add to watchlist
GDDY | $120.12 -1.01% 0.0% 1.1M
|
Technology Services
| Email alert
Add to watchlist
AAN | $7.48 2.33% 0.0% 200K
|
Finance
| Email alert
Add to watchlist
ALLY | $39.05 0.88% 0.0% 6.9M
|
Finance
| Email alert
Add to watchlist
DE | $400.32 -0.07% -0.08% 1.1M
|
Producer Manufacturing
| Email alert
Add to watchlist
OPI | $1.895 1.34% 1.32% 600K
|
Finance
| Email alert
Add to watchlist
UVE 4 | $19.62 3.32% 0.0% 160K
|
Finance
| Email alert
Add to watchlist
HIW | $24.18 0.92% 0.0% 670K
|
Finance
| Email alert
Add to watchlist
EGHT | $2.185 1.63% 1.6% 960K
|
Technology Services
| Email alert
Add to watchlist
set
Vanda Pharmaceuticals Announces Participation in the Jefferies 2023 Global Healthcare Conference
Published: 2023-06-05 (Crawled : 11:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: -0.17%
H: 1.16%
C: 0.83%
conference pharmaceuticals global
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
Published: 2023-06-02 (Crawled : 02:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.85%
H: 2.18%
C: 1.85%
vca-894 drug candidate granted treatment pharmaceuticals designation
Vanda Pharmaceuticals Announces Presentations at SLEEP 2023
Published: 2023-06-02 (Crawled : 02:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.85%
H: 2.18%
C: 1.85%
pharmaceuticals
Vanda Pharmaceuticals Announces Presentations at DDW 2023
Published: 2023-05-04 (Crawled : 22:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 0.44%
H: 1.45%
C: 0.72%
pharmaceuticals
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results on February 8, 2023
Published: 2023-02-01 (Crawled : 00:00) - prnewswire.com
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 1.04%
H: 2.84%
C: 1.03%
pharmaceuticals year financial results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.